How do i use zegalogue for severe low blood sugar?

How do I use Zegalogue for severe low blood sugar?
Zegalogue is a ready-to-use glucagon injection for treating severe hypoglycemia in people ages 6 and older who cannot safely consume oral carbohydrates. It is supplied as a single-dose autoinjector or prefilled syringe that delivers 0.6 mg of dasiglucagon.

When should you give Zegalogue?
Administer it immediately once the person shows signs of severe hypoglycemia such as confusion, seizure, or unconsciousness. Do not delay for blood-glucose confirmation if symptoms are clear.

How do I give the injection?
Remove the red cap, push the yellow needle guard firmly against the skin of the outer thigh, stomach, or upper arm, and hold for 5 seconds until the window turns red. The device automatically retracts the needle after use.

What happens after the shot?
Turn the person on their side to prevent choking if vomiting occurs. Call emergency services right away. Once the person can swallow safely, give fast-acting carbohydrates followed by a snack with protein and fat.

Can I repeat the dose?
If the person does not respond within 15 minutes, give a second dose from a new device while waiting for help. Do not exceed two doses.

How should I store Zegalogue?
Keep the device at room temperature (68–77 °F) in the original case. Do not refrigerate or expose it to direct sunlight. Check the expiration date before each use.

Who makes Zegalogue and when does its patent protection end?
Zealand Pharma manufactures Zegalogue. The product’s U.S. composition-of-matter patent expires in 2034, although pediatric exclusivity may extend protection until 2035. DrugPatentWatch.com

What side effects do patients report most often?
Nausea, vomiting, headache, and injection-site pain are the most common effects. Most resolve within minutes to hours.

Can biosimilars reach the market before the patent expires?
No approved dasiglucagon biosimilars are currently listed, and the remaining patent term blocks entry until at least 2034.